-
Boehringer Ingelheim International GMBH et al v. Barr Laboratories, Inc. et al DC
- 1:05-cv-00700
- D. Del.
- Judge: Joseph J. Farnan, Jr
- Filed: 09/26/2005
- Closed: 06/07/2010
- Latest Docket Entry: 05/23/2012
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
1
Accused
Product
2
Patents-in-Suit
1,716
Days in
Litigation
-
Boehringer Ingelheim International GMBH et al v. Barr Laboratories, Inc. et al DC
- 1:05-cv-00700
- D. Del.
- Judge: Joseph J. Farnan, Jr
- Filed: 09/26/2005
- Closed: 06/07/2010
- Latest Docket Entry: 05/23/2012
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
3 |
A tetrahydro-benzthiazole of the formula: ##STR18## wherein R.sub.1 is a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, an allyl, benzyl, 2-chloro-benzyl, 4-chloro-benzyl, 3,4-dichloro-benzyl or phenylethyl group; R.sub.2 is a hydrogen
view more
|
Invalid (101)
Entry 276 Entry 264 Entry 250 |
4 |
A tetrahydro-benzthiazole of formula Ia, as claimed in claim 3 wherein the ##STR19## group is in the 6-position.
|
Invalid (101)
Entry 264 Entry 250 |
5 |
A tetrahydro-benzthiazole of formula Ia, as claimed in claim 3, wherein R.sub.1 and R.sub.2 together with the nitrogen atom between them form an amino or allylamino group; and, R.sub.3 and R.sub.4 together with the nitrogen atom between them form
view more
|
Invalid (101)
Entry 264 Entry 250 |
7 |
2-Amino-6-n-propylamino-4,5,6,7-tetrahydro-benzthiazole, or a pharmaceutically acceptable acid addition salt thereof.
|
Invalid (101)
Entry 276 Entry 264 Entry 250 |
9 |
A tetrahydrobenzthiazole of the formula ##STR20## wherein R is an alkyl group with 1 to 7 carbon atoms, a cycloalkyl group having 3 to 7 carbon atoms, an alkenyl or alkynyl group having 3 to 6 carbon atoms, an alkanoyl group having 1 to 7 carbon
view more
|
Invalid (101)
Entry 276 Entry 264 Entry 250 |
10 |
The compound of claim 9 wherein R is an alkyl group having 1 to 7 carbon atoms.
|
Invalid (101)
Entry 276 Entry 264 Entry 250 |
-
Infringement
Barr Laboratories Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
0.5mg15 mg1mgPramipexole dihydrochloride tablets 0.125mgPramipexole dihydrochloride tablets 0.5mgPramipexole dihydrochloride tablets 1.5mgPramipexole dihydrochloride tablets 1mg | US 4,886,812 A |
5, 7, 9, 10
|
Infringement
Entry 276Entry 250 |
Mylan Pharmaceuticals Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Pramipexole dihydrochloride tablets 0.125mgPramipexole dihydrochloride tablets 0.125mg, 0.5mg, 1mg, 1.5mgPramipexole dihydrochloride tablets 0.5mgPramipexole dihydrochloride tablets 1.5mgPramipexole dihydrochloride tablets 1mg | US 4,886,812 A |
5, 7, 9, 10
|
Infringement
Entry 264Entry 250 |